Glioblastoma and brain connectivity: the need for a paradigm shift.
Journal
The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
08
12
2023
revised:
29
02
2024
accepted:
03
04
2024
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
14
6
2024
Statut:
ppublish
Résumé
Despite substantial advances in cancer treatment, for patients with glioblastoma prognosis remains bleak. The emerging field of cancer neuroscience reveals intricate functional interplays between glioblastoma and the cellular architecture of the brain, encompassing neurons, glia, and vessels. New findings underscore the role of structural and functional connections within hierarchical networks, known as the connectome. These connections contribute to the location, spread, and recurrence of a glioblastoma, and a patient's overall survival, revealing a complex interplay between the tumour and the CNS. This mounting evidence prompts a paradigm shift, challenging the perception of glioblastomas as mere foreign bodies within the brain. Instead, these tumours are intricately woven into the structural and functional fabric of the brain. This radical change in thinking holds profound implications for the understanding and treatment of glioblastomas, which could unveil new prognostic factors and surgical strategies and optimise radiotherapy. Additionally, a connectivity approach suggests that non-invasive brain stimulation could disrupt pathological neuron-glioma interactions within specific networks.
Identifiants
pubmed: 38876751
pii: S1474-4422(24)00160-1
doi: 10.1016/S1474-4422(24)00160-1
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
740-748Informations de copyright
Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Déclaration de conflit d'intérêts
Declaration of interests AS, LP, and MC report a patent pending (102022000015360; PCT IB2023/057357) for the method to compute the tract density index (“Un nuovo indice prognostico di sopravvivenza nel glioblastoma multiforme basato sulle alterazioni delle connessioni della sostanza bianca cerebrale misurato con tecniche di diffusione RM”). AB declares no competing interests.